Future Science Group
Browse
1/1
3 files

Epigenomics may begin to explain in vitro differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer. Supplementary Tables 1-3.

dataset
posted on 2023-05-22, 08:45 authored by Louis Y. El Khoury, Wan Hsin Lin, James B. Smadbeck, Dorsay Sadeghian, , Alexa F McCune, Giannoula Karagouga, John C Cheville, Michael T Barrett, Faye R Harris, Lindsey M Kinsella, Ryan W Feathers, Janet L Schafer Klein, Marina RS Walther-Antonio, Sarah H Johnson, Alan R. Penheiter, Giuseppe Cucinella, Gabriella Schivardi, Aditya BhagwateAditya Bhagwate, Mitesh J Borad, Aaron S Mansfield, Stephen J Murphy, Andrea Mariani, George Vasmatzis, Panos Z Anastasiadis, Saravut J Weroha, Alyssa M Larish

 Supplementary Tables 1-3. 

History

Usage metrics

    Epigenomics

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC